Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 IN PLASTIC CONTAINER versus SODIUM PHOSPHATES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 IN PLASTIC CONTAINER versus SODIUM PHOSPHATES.
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER vs SODIUM PHOSPHATES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium ion is essential for normal cell function, including muscle contraction, nerve transmission, and blood coagulation. It acts as a positive inotrope by increasing myocardial contractility and also corrects hypocalcemia.
Sodium phosphates act as a source of phosphate and sodium ions. Phosphate is an essential component of bone mineral, cell membranes, and energy metabolism. It also acts as a buffer in acid-base balance. In the gastrointestinal tract, hyperosmotic sodium phosphate solution draws water into the lumen, inducing bowel evacuation.
IV: 500 mg to 1 g (5-10 mL of 10% solution) administered slowly at a rate not exceeding 0.5-1 mL/min. May be repeated as needed based on serum calcium levels and clinical response.
Oral: 3.75-7.5 g (15-30 mmol phosphate) 1-4 times daily. IV: 0.3-0.5 mmol/kg over 6-12 hours.
None Documented
None Documented
2-4 hours in patients with normal renal function; prolonged in renal impairment.
Not applicable; phosphate is an endogenous ion with rapid equilibration. Serum phosphate half-life is approximately 30 minutes due to renal clearance and cellular uptake.
Primarily renal (80-90% as ionized calcium); minor fecal elimination (<10%).
Renal: >90% of absorbed phosphate is excreted renally, primarily as inorganic phosphate; fecal elimination accounts for <10%.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement